CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts
Greenblatt et al. show that deletion of CHMP5 in osteoclasts leads to increased bone resorption coupled with exuberant osteoblast activity, resembling an early onset form of human Paget’s Disease of Bone
Main Authors: | Greenblatt, Matthew B., Park, Kwang Hwan, Oh, Hwanhee, Kim, Jung-Min, Shin, Dong Yeon, Lee, Jae Myun, Lee, Jin Woo, Singh, Anju, Lee, Ki-young, Hu, Dorothy, Xiao, Changchun, Charles, Julia F., Penninger, Josef M., Lotinun, Sutada, Baron, Roland, Ghosh, Sankar, Shim, Jae-Hyuck |
---|---|
Format: | Online |
Language: | English |
Published: |
The Rockefeller University Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516796/ |
Similar Items
-
Disruption of c-Kit Signaling in KitW-sh/W-sh Growing Mice Increases Bone Turnover
by: Lotinun, Sutada, et al.
Published: (2016) -
Protein tyrosine phosphatases ε and α perform nonredundant roles in osteoclasts
by: Finkelshtein, Eynat, et al.
Published: (2014) -
CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis
by: Shim, Jae-Hyuck, et al.
Published: (2006) -
Frontotemporal Dementia Caused by CHMP2B Mutations
by: Isaacs, A.M, et al.
Published: (2011) -
Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway
by: Park, Kwang Hwan, et al.
Published: (2013)